NovoCure (NVCR) Insider Trading & Ownership $16.59 +0.41 (+2.53%) (As of 11/4/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends NovoCure (NASDAQ:NVCR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.29%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$193,742.47 Get NVCR Insider Trade Alerts Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NVCR Insider Buying and Selling by Quarter Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration. Watch this new documentary and you’ll discover what Elon knows, NovoCure Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2024Frank X LeonardEVPSell598$15.94$9,532.12 11/1/2024Mukund ParavasthuCOOSell160$15.88$2,540.80 10/31/2024Michal Nath PuriInsiderSell810$15.79$12,789.90 8/2/2024Ashley CordovaCFOSell688$20.14$13,856.32 6/4/2024W Anthony VernonDirectorSell964$23.89$23,029.96 3/4/2024Frank X LeonardEVPSell840$16.01$13,448.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/4/2024Wilhelmus Cm GroenhuysenCOOSell1,217$16.01$19,484.17 3/1/2024Frank X LeonardEVPSell1,679$16.03$26,914.37 3/1/2024Wilhelmus Cm GroenhuysenCOOSell2,107$16.03$33,775.21 2/28/2024Frank X LeonardEVPSell2,078$16.14$33,538.92 11/7/2023Pritesh ShahInsiderSell382$12.65$4,832.30 (Data available from 1/1/2013 forward) NVCR Insider Trading Activity - Frequently Asked Questions Who is on NovoCure's Insider Roster? The list of insiders at NovoCure includes Asaf Danziger, Ashley Cordova, Ely Benaim, Frank X Leonard, Jeryl L Hilleman, Michal Nath Puri, Mukund Paravasthu, Pritesh Shah, Todd Christopher Longsworth, Uri Weinberg, W Anthony Vernon, Wilhelmus Cm Groenhuysen, and William F Doyle. Learn more on insiders at NVCR. What percentage of NovoCure stock is owned by insiders? 6.29% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings. Which NovoCure insiders have been selling company stock? The following insiders have sold NVCR shares in the last 24 months: Asaf Danziger ($23,107,250.00), Ashley Cordova ($200,962.66), Frank X Leonard ($371,884.81), Michal Nath Puri ($12,789.90), Mukund Paravasthu ($2,540.80), Pritesh Shah ($10,789.16), Uri Weinberg ($945,728.02), W Anthony Vernon ($23,029.96), and Wilhelmus Cm Groenhuysen ($224,917.50). How much insider selling is happening at NovoCure? Insiders have sold a total of 241,721 NovoCure shares in the last 24 months for a total of $24,899,892.81 sold. NovoCure Key ExecutivesMr. William F. Doyle (Age 62)Executive Chairman Compensation: $1.43MMr. Asaf Danziger (Age 58)CEO & Director Compensation: $1.52MMs. Ashley Cordova (Age 45)Chief Financial Officer Compensation: $814.81k1 recent tradesMr. Wilhelmus C. M. Groenhuysen (Age 66)Chief Operating Officer Compensation: $965.56kMr. Barak Ben Arye (Age 47)General Counsel Compensation: $761.97kMr. Frank LeonardExecutive VP & President of Novocure Oncology1 recent tradesProf. Yoram Palti M.D. (Age 86)Ph.D., Founder & CTO Compensation: $282.51kDr. Moshe Giladi Ph.D. (Age 54)Chief Science Officer Ms. Ingrid GoldbergVP of Investor RelationsMr. Michael Puri (Age 55)Chief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies NVRO Insider Transactions GKOS Insider Transactions INSP Insider Transactions PRCT Insider Transactions TMDX Insider Transactions AXNX Insider Transactions NVST Insider Transactions LIVN Insider Transactions NARI Insider Transactions IRTC Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:NVCR) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.